The best of R&I and around the web, handpicked by our editors.
White papers, service directory and conferences for the R&I community.
Web replica of the print magazine.
Healthesystems is a leading provider of Pharmacy Benefit Management (PBM) & Ancillary Benefits Management programs for the workers' compensation industry.
The utilization of GLP-1 drugs has skyrocketed over the last few years. As a new component of healthcare what strategies and insights should the workers’ comp industry consider when evaluating and managing these medications?
Drug shortages are no longer just a pharmacy issue but a growing claims management risk in workers’ compensation, contributing to more complex claims, delayed care, and higher costs.
As part of our continuing Social Determinants of Health (SDoH) series, we examine how low health literacy can delay recovery, increase costs, and worsen claim outcomes.
Pharmacy activity in the earliest stages of a workers’ compensation claim can serve as a measurable signal of elevated risk for future complexity, cost, and duration.
The medications used to treat lung diseases are diverse. While patient-specific factors can help determine course of treatment, there are larger considerations for the pharmacy management of lung conditions.
Effective pharmacy workflows pair greater efficiency with better health outcomes, reducing burden for claims professionals while increasing impact.
The recent rescheduling of marijuana could be a boon to clinical research on pain management. What is marijuana’s potential role in treating pain?
More complex and costly claims have become a persistent issue in workers’ compensation. Understanding the contributors to claim complexity is the first step to mitigating and managing these claims.
Patient engagement programs are a staple in American healthcare and increasingly common in WC. By focusing engagement strategies on desirable behaviors in injured workers, payers and partners can achieve positive results.
Unfamiliarity with workers’ comp is one of the biggest barriers to recovery for injured worker patients. How can we use meaningful engagement to help them navigate the system?
While the recent rescheduling of marijuana mainly applies to medical products and not recreational use, it does introduce significant implications for clinical research, drug development, and downstream utilization in patient care.
Occupational lung diseases make up a small but significant portion of workers’ comp claims, and an uptick in wildfires across the U.S. has increased the frequency of these claims among firefighters.
Demand for DME is rising, as are costs. What’s driving this growth, and how can the workers’ compensation industry contain costs?
With the workforce growing older, degenerative conditions may have a growing impact on claims. Here are six common conditions that injured workers face.
Explore the top five major findings from this year’s Workers’ Comp Industry Insights Survey
Utah’s prescription renewal pilot is a groundbreaking use case for AI in healthcare. What are the potential benefits and pitfalls?
While cases may be few, long COVID can significantly impact workers’ comp claims in several ways.
The FDA has approved the first oral version of a GLP-1 for the treatment of obesity. What do you need to know about safety, efficacy, and cost?
In workers’ comp, comorbidities like hypertension require a focus on drug-drug and drug-disease interactions to ensure effective and safe treatment plans.
Out-of-network pharmacy use in workers’ compensation drives higher costs, safety risks, and regulatory gaps; educating and engaging injured workers through digital outreach is a critical lever to increase network utilization.
Newsletters
Risk Central
Digital Edition
